Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 3, 2020

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
Covid19
Interventions
DEVICE

CytoSorb

"CRRT with CytoSorb.Nevertheless , patients will be uniquely in CVVHD mode in order to measure only the CytoSorb Effect.~First 24 h : the CytoSorb should be changed after 12 h as we forecast a huge cytokine storm in the first 24 hours.~After the initial 24 h, cartridge change will occur every 24 hours up a maximum of 96 h in total in the inflammation storm persist."

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Dr David DE BELS

OTHER

NCT04518969 - Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 | Biotech Hunter | Biotech Hunter